Pharsight

Drugs that contain Benzoyl Peroxide; Tretinoin

1. Twyneo patents expiration

Can you believe TWYNEO received compensation for the extended wait time during the regulatory approval process?
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8617580 GALDERMA LABS LP Compositions for topical application comprising a peroxide and retinoid
Feb, 2028

(3 years from now)

US9868103 GALDERMA LABS LP Metal oxide coating of water insoluble ingredients
Aug, 2028

(4 years from now)

US10653899 GALDERMA LABS LP Core stabilized microcapsules, method of their preparation and uses thereof
Dec, 2030

(6 years from now)

US11071878 GALDERMA LABS LP Core stabilized microcapsules, method of their preparation and uses thereof
Dec, 2030

(6 years from now)

US10420743 GALDERMA LABS LP Methods and compositions for the treatment of acne
Jul, 2038

(14 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Combination (NC) Jul 26, 2024

Market Authorisation Date: 26 July, 2021

Treatment: Topical treatment of acne vulgaris in adults and pediatric patients 9 years of age and older

Dosage: CREAM;TOPICAL

More Information on Dosage

TWYNEO family patents

Family Patents